Yunjie Wang

机构：China Pharmaceutical University · ORCID：0009-0009-1133-6718

发表论文 137 篇 · 总被引 2297 次 · h-index 26

代表论文

• The etiology of poststroke-depression: a hypothesis involving HPA axis (2022 · Biomedicine & Pharmacotherapy · 被引 117)
• Medioresinol as a novel PGC-1α activator prevents pyroptosis of endothelial cells in ischemic stroke through PPARα-GOT1 axis (2021 · Pharmacological Research · 被引 116)
• A novel PGAM5 inhibitor LFHP-1c protects blood–brain barrier integrity in ischemic stroke (2021 · Acta Pharmaceutica Sinica B · 被引 56)
• Discovery of Natural Resorcylic Acid Lactones as Novel Potent Copper Ionophores Covalently Targeting PRDX1 to Induce Cuproptosis for Triple-Negative Breast Cancer Therapy (2025 · ACS Central Science · 被引 32)
• Escin avoids hemorrhagic transformation in ischemic stroke by protecting BBB through the AMPK/Cav-1/MMP-9 pathway (2023 · Phytomedicine · 被引 30)
• Ferroptosis in Ischemic Stroke and Related Traditional Chinese Medicines (2024 · Molecules · 被引 16)